In vital services such as healthcare, technology that drains efficiency has a much more severe impact than employee frustration. When data is confined within spreadsheets that must be manually updated as changes occur, communication and accessibility across departments suffer, ultimately leading to repercussions on patient care.
Embracing multi-resource planning technology can mark a significant shift, offering dynamic solutions that adapt to rapidly changing departmental environments. By eliminating the productivity drain, pharma companies can focus on core objectives, from drug development to clinical trials, without unnecessary hindrances.
With streamlined resource allocation, pharma stakeholders can maximise available resources, minimising disruptions and enhancing productivity during challenging times. An event such as COVID-19 was unexpected. Still, it demonstrated that managing resources must provide a holistic view of resources and take advantage of the latest technologies to enhance visibility for key stakeholders and remove complications. In or outside of a global pandemic, a platform where all resources can be catalogued, viewed, and organised with the familiar drag-and-drop motion within one interface is game-changing.
The old systems have been effective, but can easily break down when rapid change occurs, the personnel that manage them are unavailable, or pressure suddenly overwhelms these processes. When a traditional planning and scheduling system for people, locations, and equipment must be overhauled due to an unexpected change, time and resources are lost responding to it. During such events, the operational system should support personnel, not add to the workload.
Multi-resource planning technology empowers pharmaceutical companies with real-time insights into resource availability, allowing them to adapt swiftly to unforeseen challenges. With enhanced agility, pharma stakeholders can effectively manage crises and maintain operations, safeguarding the continuity of patient care and employee wellbeing.
The necessity for effective resource planning and allocation in a rapidly evolving pharmaceutical landscape cannot be overstated. By embracing multi-resource planning technology, pharma stakeholders can address the productivity drain, revolutionise departmental functionality, and quickly navigate uncertain environments. This investment in technology streamlines services and encourages collaboration across healthcare services, ultimately leading to improved patient care.
As the industry evolves, companies prioritising the right technology to assist administration will be better equipped to thrive amidst challenges, ensuring success in drug development, clinical trials, and healthcare delivery. With multi-resource planning technology at their disposal, pharmaceutical professionals can unlock the industry’s true potential, revolutionising patient care and transforming the future of healthcare.
Stephane Bensoussan is the head of operations at dizmo and the product owner of Planisy, the latest product powered by dizmo’s technology. Through his extensive industrial and technical background, Bensoussan brings over 30 years of experience working in high-tech environments across marketing, sales, business development, operations, strategic partnerships, and R&D. He is a cross-disciplinary individual who has the ability to bring new innovations to the market.